| Product NDC: | 0149-0470 |
| Proprietary Name: | ACTONEL |
| Non Proprietary Name: | RISEDRONATE SODIUM |
| Active Ingredient(s): | 30 mg/1 & nbsp; RISEDRONATE SODIUM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0149-0470 |
| Labeler Name: | Warner Chilcott Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020835 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980327 |
| Package NDC: | 0149-0470-01 |
| Package Description: | 12 BOTTLE in 1 CASE (0149-0470-01) > 30 TABLET, FILM COATED in 1 BOTTLE |
| NDC Code | 0149-0470-01 |
| Proprietary Name | ACTONEL |
| Package Description | 12 BOTTLE in 1 CASE (0149-0470-01) > 30 TABLET, FILM COATED in 1 BOTTLE |
| Product NDC | 0149-0470 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | RISEDRONATE SODIUM |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19980327 |
| Marketing Category Name | NDA |
| Labeler Name | Warner Chilcott Pharmaceuticals Inc. |
| Substance Name | RISEDRONATE SODIUM |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |